跳至主要内容
临床试验/JPRN-UMIN000039580
JPRN-UMIN000039580招募中未知

The efficacy of HCV eradication with direct-acting antivirals on patients with cirrhosis - The efficacy of HCV clearance

Chiba University Graduate School of Medicine0 个研究点目标入组 20 人开始时间: 2020年2月24日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 未提供

研究者

发起方
Chiba University Graduate School of Medicine

相似试验

招募中
不适用
Antiviral therapy for HCV using direct acting antiviral drugs in patients with chronic hepatitis C undergoing hemodialysis.Patients with HCV genotype 1B infection who are undergoing maintenance hemodialysis.
JPRN-UMIN000017023Ogaki Municipal Hospital150
进行中(未招募)
1 期
Direct acting antiviral therapy of hepatitis C in Denmark: treatment response, adverse events and resistance associated variantsPatients with chronic hepatitis CMedDRA version: 19.1Level: LLTClassification code 10074391Term: Chronic hepatitis C virus genotype 1System Organ Class: 100000004862
EUCTR2015-001956-31-DKDepartment of Infectious Diseases, Copenhagen University Hospital, Hvidovre.111
进行中(未招募)
1 期
treatment of eradication of HCV infection in immigrant patients with innovative drugChronic HCV hepatitis, all fibrosisMedDRA version: 20.1Level: PTClassification code 10008912Term: Chronic hepatitis CSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: PTClassification code 10019755Term: Hepatitis chronic activeSystem Organ Class: 10019805 - Hepatobiliary disorders
EUCTR2017-001024-21-ITA.O.U. Università degli Studi della Campania Luigi Vanvitelli6,000
招募中
不适用
The efficacy of H. pylori eradication therapy with sitafloxacin-metronidazole-vonaprazan 10 day regime
JPRN-UMIN000022236Keio University School of Medicine100
招募中
不适用
The efficacy of H. pylori eradication therapy with sitafloxacin-metronidazole-vonaprazan regimeHelicobacter pylori infection
JPRN-jRCTs031180412Hirata Kenro100